Recently, the results of two Phase III clinical studies (DREAMS-1 and DREAMS-2) of mazdutide in Chinese patients with type 2 diabetes mellitus (T2DM) have been jointly published in the prestigious journal Nature.Following presentations at the Scientific Sessions of the American Diabetes Association (ADA) and the Annual Meeting of the European Association for the Study of […]